e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Systemic and airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Periostin in lower airway samples and serum, a novel asthma marker?
Katarzyna Górska (Warsaw, Poland), Katarzyna Górska, Patrycja Nejman-Gryz, Piotr Korczynski, Monika Prochorec-Sobieszek, Rafal Krenke
Source:
International Congress 2015 – Systemic and airway biomarkers
Session:
Systemic and airway biomarkers
Session type:
Thematic Poster Session
Number:
3880
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Katarzyna Górska (Warsaw, Poland), Katarzyna Górska, Patrycja Nejman-Gryz, Piotr Korczynski, Monika Prochorec-Sobieszek, Rafal Krenke. Periostin in lower airway samples and serum, a novel asthma marker?. Eur Respir J 2015; 46: Suppl. 59, 3880
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Are there differences in the bronchoalveolar lavage (BAL) cytokine profile in children with and without allergic asthma?
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Airway wall eosinophilia in severe asthmatic children: predictive values for noninvasive tests
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant?
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Lung microbiome is associated with asthma severity in fungal associated asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Assessment of ATP degradation in bronchoalveolar lavage fluid
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Inflammatory cytokine levels in serum and bronchoalveolar lavage fluid and gene polymorphism in young adult patients with bronchiectasis
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Which BAL fluid (BALF) analyses are clinically useful in immunocomptent children?
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept